Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank-check company sponsored by affiliates of Oaktree Capital Management, the Los Angeles-based alternative investment firm. The SPAC targets the life sciences sector, reflecting Oaktree's focus on healthcare and biotechnology opportunities. OACC filed a Form 10-Q with the SEC on May 13, 2026, accession number 0001193125-26-221814, indicating the vehicle remains in its search phase and has not yet announced a definitive business combination agreement. This is the third SPAC vehicle Oaktree has brought to market under the Acquisition Corp. series. Investors and analysts tracking pre-deal life sciences SPACs can sign up at SpacDesk for full filing history, timeline analytics, and real-time status updates on OACC and hundreds of other active vehicles.